David Kirske is Chief Financial Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 193,254 shares of XFOR, which is worth approximately $593,289. The most recent transaction as insider was on Aug 14, 2025, when has been sold 193,254 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K
n/a 3M change
n/a 12M change
Total Value Held $593,289

DAVID KIRSKE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2025
BUY
Grant, award, or other acquisition
-
193,254 Added 50.0%
193,254 Common Stock

Also insider at

CTIC
CTI BIOPHARMA CORP Healthcare
DK

David Kirske

Chief Financial Officer
Seattle, WA

Track Institutional and Insider Activities on XFOR

Follow X4 Pharmaceuticals, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

News

Receive news related to X4 Pharmaceuticals, Inc

Track Activities on XFOR